Načítá se...
Eldecalcitol, an Active Vitamin D(3) Derivative, Prevents Trabecular Bone Loss and Bone Fragility in Type I Diabetic Model Rats
Diabetes mellitus is known to adversely affect the bones and be associated with increased fracture risk. We examined whether eldecalcitol (ELD), an active vitamin D(3) derivative, could inhibit the diabetic bone loss in streptozotocin-induced type I diabetic rats. ELD (10, 20, or 40 ng/kg), alfacalc...
Uloženo v:
| Vydáno v: | Calcif Tissue Int |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5587631/ https://ncbi.nlm.nih.gov/pubmed/28624935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-017-0298-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|